Amneal Pharmaceuticals, Inc 10-K for FY2024
Amneal Pharmaceuticals, Inc. (AMRX)
10-K
2025-02-28
For: 2024-12-31
View Original
Added on
April 06, 2026
About this 10-K
Amneal Pharmaceuticals, Inc filed this 10-K on February 28, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $2.79B
- up 16.7% from $2.39B a year earlier
- Net loss
- $73.88M
- compared with a net loss of $48.72M a year earlier
- Diluted EPS
- -$0.38
- compared with -$0.48 a year earlier